MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6

Prostate cancer (PCa) is one of the leading causes of cancer-related death in males worldwide and exploring more reliable biomarkers for PCa is essential for the diagnosis and therapeutics for the disease. Although the functions of miR-141-3p and AlkB homolog 5 (ALKBH5) were identified in some cance...

Full description

Bibliographic Details
Main Authors: Xun Li, Bide Liu, Shuheng Wang, Jiuzhi Li, Xiaohu Ge
Format: Article
Language:English
Published: Wolters Kluwer Medknow Publications 2023-01-01
Series:Chinese Journal of Physiology
Subjects:
Online Access:http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2023;volume=66;issue=1;spage=43;epage=51;aulast=Li
_version_ 1797775269907398656
author Xun Li
Bide Liu
Shuheng Wang
Jiuzhi Li
Xiaohu Ge
author_facet Xun Li
Bide Liu
Shuheng Wang
Jiuzhi Li
Xiaohu Ge
author_sort Xun Li
collection DOAJ
description Prostate cancer (PCa) is one of the leading causes of cancer-related death in males worldwide and exploring more reliable biomarkers for PCa is essential for the diagnosis and therapeutics for the disease. Although the functions of miR-141-3p and AlkB homolog 5 (ALKBH5) were identified in some cancers, whether they were involved in the development of PCa remains unclear. In this study, reverse transcription-quantitative polymerase chain reaction unveiled that the expression of ALKBH5 was reduced in PCa tissues and was negatively correlated with miR-141-3p. ALKBH5 attenuated the malignant development of PCa through suppressing the growth, migration, invasion, and sphere formation abilities of PCa cells. In addition, the luciferase activity assay identified that ALKBH5 was corroborated as a downstream target of miR-141-3p. Moreover, miR-141-3p expression was boosted in PCa tissues and cells and inhibition of miR-141-3p suppressed the tumor growth of PCa in vivo. Moreover, ALKBH5 was confirmed to suppress protein arginine methyltransferase 6 (PRMT6) expression through N6-methyladenosine (m6A) modification. We further identified that miR-141-3p-modulated PRMT6 level through mediating ALKBH5. Furthermore, PRMT6 level was positively correlated with miR-141-3p level and negatively associated with ALKBH5 level. Finally, rescue assays also uncovered that miR-141-3p aggravated PCa development by regulating PRMT6. In conclusion, miR-141-3p accelerated the malignant progression of PCa through ALKBH5-mediated m6A modification of PRMT6, which might offer a novel insight into the role of miR-141-3p and ALKBH5 in the treatments of PCa patients.
first_indexed 2024-03-12T22:33:19Z
format Article
id doaj.art-336269bae2024efeb1842a7b00971bb3
institution Directory Open Access Journal
issn 0304-4920
2666-0059
language English
last_indexed 2024-03-12T22:33:19Z
publishDate 2023-01-01
publisher Wolters Kluwer Medknow Publications
record_format Article
series Chinese Journal of Physiology
spelling doaj.art-336269bae2024efeb1842a7b00971bb32023-07-21T14:32:58ZengWolters Kluwer Medknow PublicationsChinese Journal of Physiology0304-49202666-00592023-01-01661435110.4103/cjop.CJOP-D-22-00071MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6Xun LiBide LiuShuheng WangJiuzhi LiXiaohu GeProstate cancer (PCa) is one of the leading causes of cancer-related death in males worldwide and exploring more reliable biomarkers for PCa is essential for the diagnosis and therapeutics for the disease. Although the functions of miR-141-3p and AlkB homolog 5 (ALKBH5) were identified in some cancers, whether they were involved in the development of PCa remains unclear. In this study, reverse transcription-quantitative polymerase chain reaction unveiled that the expression of ALKBH5 was reduced in PCa tissues and was negatively correlated with miR-141-3p. ALKBH5 attenuated the malignant development of PCa through suppressing the growth, migration, invasion, and sphere formation abilities of PCa cells. In addition, the luciferase activity assay identified that ALKBH5 was corroborated as a downstream target of miR-141-3p. Moreover, miR-141-3p expression was boosted in PCa tissues and cells and inhibition of miR-141-3p suppressed the tumor growth of PCa in vivo. Moreover, ALKBH5 was confirmed to suppress protein arginine methyltransferase 6 (PRMT6) expression through N6-methyladenosine (m6A) modification. We further identified that miR-141-3p-modulated PRMT6 level through mediating ALKBH5. Furthermore, PRMT6 level was positively correlated with miR-141-3p level and negatively associated with ALKBH5 level. Finally, rescue assays also uncovered that miR-141-3p aggravated PCa development by regulating PRMT6. In conclusion, miR-141-3p accelerated the malignant progression of PCa through ALKBH5-mediated m6A modification of PRMT6, which might offer a novel insight into the role of miR-141-3p and ALKBH5 in the treatments of PCa patients.http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2023;volume=66;issue=1;spage=43;epage=51;aulast=Limir-141-3pprostate canceralkb homolog 5m6aprotein arginine methyltransferase 6
spellingShingle Xun Li
Bide Liu
Shuheng Wang
Jiuzhi Li
Xiaohu Ge
MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6
Chinese Journal of Physiology
mir-141-3p
prostate cancer
alkb homolog 5
m6a
protein arginine methyltransferase 6
title MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6
title_full MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6
title_fullStr MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6
title_full_unstemmed MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6
title_short MiR-141-3p promotes malignant progression in prostate cancer through AlkB homolog 5-mediated m6A modification of protein arginine methyltransferase 6
title_sort mir 141 3p promotes malignant progression in prostate cancer through alkb homolog 5 mediated m6a modification of protein arginine methyltransferase 6
topic mir-141-3p
prostate cancer
alkb homolog 5
m6a
protein arginine methyltransferase 6
url http://www.cjphysiology.org/article.asp?issn=0304-4920;year=2023;volume=66;issue=1;spage=43;epage=51;aulast=Li
work_keys_str_mv AT xunli mir1413ppromotesmalignantprogressioninprostatecancerthroughalkbhomolog5mediatedm6amodificationofproteinargininemethyltransferase6
AT bideliu mir1413ppromotesmalignantprogressioninprostatecancerthroughalkbhomolog5mediatedm6amodificationofproteinargininemethyltransferase6
AT shuhengwang mir1413ppromotesmalignantprogressioninprostatecancerthroughalkbhomolog5mediatedm6amodificationofproteinargininemethyltransferase6
AT jiuzhili mir1413ppromotesmalignantprogressioninprostatecancerthroughalkbhomolog5mediatedm6amodificationofproteinargininemethyltransferase6
AT xiaohuge mir1413ppromotesmalignantprogressioninprostatecancerthroughalkbhomolog5mediatedm6amodificationofproteinargininemethyltransferase6